Zomedica Corp. Quarterly Debt-to-equity in % from Q3 2020 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Zomedica Corp. quarterly Debt-to-equity history and growth rate from Q3 2020 to Q2 2024.
Zomedica Corp. Debt-to-equity for the quarter ending June 30, 2024 was 5.34 %, a 1.66% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	5.34	-0.09	-1.66%	Jun 30, 2024
Q1 2024	5.49	+0.65	+13.4%	Mar 31, 2024
Q4 2023	5.78	+1.68	+41%	Dec 31, 2023
Q3 2023	5.54	+1.7	+44.3%	Sep 30, 2023
Q2 2023	5.44	+2.31	+74%	Jun 30, 2023
Q1 2023	4.84	+2.2	+83.4%	Mar 31, 2023
Q4 2022	4.1	+2.03	+98.1%	Dec 31, 2022
Q3 2022	3.84	+1.98	+107%	Sep 30, 2022
Q2 2022	3.12	+1.16	+59.2%	Jun 30, 2022
Q1 2022	2.64	-0.16	-5.73%	Mar 31, 2022
Q4 2021	2.07	-5.32	-72%	Dec 31, 2021
Q3 2021	1.86	-7.66	-80.4%	Sep 30, 2021
Q2 2021	1.96			Jun 30, 2021
Q1 2021	2.79			Mar 31, 2021
Q4 2020	7.39			Dec 31, 2020
Q3 2020	9.52			Sep 30, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.